Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166291 | SCV000217074 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704216 | SCV000515465 | likely benign | not provided | 2021-09-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22495361) |
Labcorp Genetics |
RCV000528272 | SCV000624633 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-06-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166291 | SCV000690192 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002267916 | SCV002552292 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002267916 | SCV002556095 | likely benign | not specified | 2022-06-23 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995497 | SCV004841217 | likely benign | Lynch syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004739533 | SCV005354480 | likely benign | MSH6-related disorder | 2024-08-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |